🔎 Trials Near Me

Domov › Rak jajčnikov › Wisconsin

Klinične študije za Rak jajčnikov v Wisconsin

29 študij za Rak jajčnikov išče udeležence na lokacijah v Wisconsin.

Mesta v Wisconsin

Uradno besedilo študije (angleško)

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

  • ThedaCare Regional Cancer Center, Appleton
  • ThedaCare Regional Medical Center - Appleton, Appleton
  • Duluth Clinic Ashland, Ashland
  • in še 42
Vključevanje udeležencevFaza 2
Vse starosti · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT05564377

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

  • University of Wisconsin Carbone Cancer Center, Madison
Vključevanje udeležencevFaza 1/2
Starost 12 in več · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT04585750

A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

  • UW Health Carbone Cancer Center, Madison
Vključevanje udeležencevFaza 2
Starost 18 in več · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT06760819

A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation

  • Research Site, Milwaukee
Vključevanje udeležencevFaza 1
Starost 18 in več · Vsi spoli · Posodobljeno 29. sep. 2026 · NCT05877599

Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer

  • Mayo Clinic Health System - Northwest Wisconsin, Eau Claire
  • Mayo Clinic Health System - Southwest Wisconsin, La Crosse
Vključevanje udeležencevOpazovalna študija
Starost 18 in več · Ženske · Posodobljeno 29. sep. 2026 · NCT05051722

Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)

  • Research Site, Madison
Vključevanje udeležencevFaza 2
Starost 18–130 · Vsi spoli · Posodobljeno 23. sep. 2026 · NCT05489211

A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

  • University of Wisconsin Carbone Cancer Center - University Hospital, Madison
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07213804

A Study of LY4337713 in Participants With FAP-Positive Solid Tumors

  • University of Wisconsin - Carbone Cancer Center, Madison
Vključevanje udeležencevFaza 1
Starost 18 in več · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07213791

A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations

  • Froedtert & MCW Cancer Center, Milwaukee
Vključevanje udeležencevFaza 1/2
Starost 18 in več · Vsi spoli · Posodobljeno 17. sep. 2026 · NCT07109726

Phase 3 Trial Evaluating the Safety & Efficacy of IMNN-001 Administered in Combination w/ Standard NACT & Adjuvant Chemotherapy in Newly Diagnosed Patients w/ Advanced EOC, Fallopian Tube or Primary Peritoneal Cancer

  • Froedtert and The Medical College of Wisconsin, Milwaukee
Vključevanje udeležencevFaza 3
Starost 18 in več · Ženske · Posodobljeno 15. sep. 2026 · NCT06915025

A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression

  • Froedtert & the Medical College of Wisconsin, Milwaukee
Vključevanje udeležencevFaza 2
Starost 18–99 · Ženske · Posodobljeno 15. sep. 2026 · NCT07023627

Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression

  • Prohealth Care, Waukesha
Vključevanje udeležencevFaza 3
Starost 18 in več · Ženske · Posodobljeno 15. sep. 2026 · NCT07214779

Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer

  • University of Wisconsin, Madison
  • Medical College of Wisconsin, Milwaukee
Vključevanje udeležencevFaza 2
Starost 18 in več · Ženske · Posodobljeno 14. sep. 2026 · NCT06787612

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

  • ThedaCare Regional Cancer Center, Appleton
Vključevanje udeležencevOpazovalna študija
Starost 18 in več · Vsi spoli · Posodobljeno 14. sep. 2026 · NCT05059444

The Vanguard Study: Testing a New Way to Screen for Cancer

  • Zablocki Veterans Administration Medical Center, Milwaukee
Vključevanje udeležencevVabljeni zdravi prostovoljci
Starost 45–75 · Vsi spoli · Posodobljeno 2. sep. 2026 · NCT06995898

Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma

  • Froedtert Hospital & the Medical College of Wisconsin, Milwaukee
Vključevanje udeležencevFaza 1
Starost 18 in več · Vsi spoli · Posodobljeno 27. avg. 2026 · NCT06582017

Cognitive Impact of Neoadjuvant Chemotherapy for Gynecologic Cancers

  • UW Carbone Cancer Center, Madison
Vključevanje udeležencevOpazovalna študija
Starost 18 in več · Ženske · Posodobljeno 27. avg. 2026 · NCT07125209

Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity

  • University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
  • University of Wisconsin Carbone Cancer Center - University Hospital, Madison
  • Marshfield Medical Center-Marshfield, Marshfield
  • in še 6
Vključevanje udeležencevFaza 2/3
Starost 18 in več · Vsi spoli · Posodobljeno 19. avg. 2026 · NCT07001748

A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer

  • Aurora Cancer Care-Southern Lakes VLCC, Burlington
  • Aurora Saint Luke's South Shore, Cudahy
  • Aurora Health Care Germantown Health Center, Germantown
  • in še 20
Vključevanje udeležencev
Starost 35–50 · Ženske · Posodobljeno 7. avg. 2026 · NCT04251052

Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

  • Duluth Clinic Ashland, Ashland
  • Northwest Wisconsin Cancer Center, Ashland
  • Aurora Cancer Care-Southern Lakes VLCC, Burlington
  • in še 33
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 7. avg. 2026 · NCT06580314

A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

  • Froedtert and the Medical College of Wisconsin, Milwaukee
Vključevanje udeležencevFaza 2/3
Starost 18 in več · Vsi spoli · Posodobljeno 28. jul. 2026 · NCT06161025

Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers

  • 121, Milwaukee
Vključevanje udeležencevFaza 2
Starost 18 in več · Ženske · Posodobljeno 16. jul. 2026 · NCT06906341

An Evaluation of Maintenance Therapy Combination Mirvetuximab Soravtansine and Olaparib

  • University of Wisconsin - Carbone Cancer Center - University Hospital, Madison
Vključevanje udeležencevFaza 2
Starost 18–100 · Ženske · Posodobljeno 13. jul. 2026 · NCT05887609

Lead-212 PSV359 Therapy for Patients With Solid Tumors

  • University of Wisconsin, Madison
Vključevanje udeležencevFaza 1/2
Starost 18–90 · Vsi spoli · Posodobljeno 6. jul. 2026 · NCT06710756

Integrated Cancer Repository for Cancer Research

  • Bellin Memorial Hospital, Green Bay
Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
Starost 19–110 · Vsi spoli · Posodobljeno 29. jun. 2026 · NCT02012699

SynKIR-110 for Mesothelin Expressing Ovarian Cancer, Cholangiocarcinoma or Mesothelioma

  • University of Wisconsin Carbone Cancer Center, Madison
Vključevanje udeležencevFaza 1
Starost 18 in več · Vsi spoli · Posodobljeno 24. jun. 2026 · NCT05568680

Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer

  • Froedtert Memorial Lutheran Hospital & Medical College of Wisconsin, Milwaukee
Vključevanje udeležencevFaza 3
Starost 18 in več · Ženske · Posodobljeno 16. apr. 2026 · NCT05659381

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Milwaukee
Vključevanje udeležencevOpazovalna študija
Vse starosti · Vsi spoli · Posodobljeno 28. okt. 2025 · NCT03452774

Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.